1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Iron Deficiency Anemia Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Oral Iron Therapy 1.2.3 Parenteral Iron Therapy 1.2.4 Red Blood Cell Transfusion 1.2.5 Other 1.3 Market by Application 1.3.1 Global Iron Deficiency Anemia Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Home Healthcare 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Iron Deficiency Anemia Therapy Market Perspective (2017-2028) 2.2 Iron Deficiency Anemia Therapy Growth Trends by Region 2.2.1 Iron Deficiency Anemia Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Iron Deficiency Anemia Therapy Historic Market Size by Region (2017-2022) 2.2.3 Iron Deficiency Anemia Therapy Forecasted Market Size by Region (2023-2028) 2.3 Iron Deficiency Anemia Therapy Market Dynamics 2.3.1 Iron Deficiency Anemia Therapy Industry Trends 2.3.2 Iron Deficiency Anemia Therapy Market Drivers 2.3.3 Iron Deficiency Anemia Therapy Market Challenges 2.3.4 Iron Deficiency Anemia Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Iron Deficiency Anemia Therapy Players by Revenue 3.1.1 Global Top Iron Deficiency Anemia Therapy Players by Revenue (2017-2022) 3.1.2 Global Iron Deficiency Anemia Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Iron Deficiency Anemia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Iron Deficiency Anemia Therapy Revenue 3.4 Global Iron Deficiency Anemia Therapy Market Concentration Ratio 3.4.1 Global Iron Deficiency Anemia Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Iron Deficiency Anemia Therapy Revenue in 2021 3.5 Iron Deficiency Anemia Therapy Key Players Head office and Area Served 3.6 Key Players Iron Deficiency Anemia Therapy Product Solution and Service 3.7 Date of Enter into Iron Deficiency Anemia Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Iron Deficiency Anemia Therapy Breakdown Data by Type 4.1 Global Iron Deficiency Anemia Therapy Historic Market Size by Type (2017-2022) 4.2 Global Iron Deficiency Anemia Therapy Forecasted Market Size by Type (2023-2028) 5 Iron Deficiency Anemia Therapy Breakdown Data by Application 5.1 Global Iron Deficiency Anemia Therapy Historic Market Size by Application (2017-2022) 5.2 Global Iron Deficiency Anemia Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Iron Deficiency Anemia Therapy Market Size (2017-2028) 6.2 North America Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) 6.3 North America Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Iron Deficiency Anemia Therapy Market Size (2017-2028) 7.2 Europe Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) 7.3 Europe Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Iron Deficiency Anemia Therapy Market Size (2017-2028) 8.2 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Iron Deficiency Anemia Therapy Market Size (2017-2028) 9.2 Latin America Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) 9.3 Latin America Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Iron Deficiency Anemia Therapy Market Size (2017-2028) 10.2 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Allergan 11.1.1 Allergan Company Detail 11.1.2 Allergan Business Overview 11.1.3 Allergan Iron Deficiency Anemia Therapy Introduction 11.1.4 Allergan Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.1.5 Allergan Recent Development 11.2 AMAG Pharmaceuticals 11.2.1 AMAG Pharmaceuticals Company Detail 11.2.2 AMAG Pharmaceuticals Business Overview 11.2.3 AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Introduction 11.2.4 AMAG Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.2.5 AMAG Pharmaceuticals Recent Development 11.3 Integra Lifesciences 11.3.1 Integra Lifesciences Company Detail 11.3.2 Integra Lifesciences Business Overview 11.3.3 Integra Lifesciences Iron Deficiency Anemia Therapy Introduction 11.3.4 Integra Lifesciences Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.3.5 Integra Lifesciences Recent Development 11.4 Galderma Pharma 11.4.1 Galderma Pharma Company Detail 11.4.2 Galderma Pharma Business Overview 11.4.3 Galderma Pharma Iron Deficiency Anemia Therapy Introduction 11.4.4 Galderma Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.4.5 Galderma Pharma Recent Development 11.5 Teoxane 11.5.1 Teoxane Company Detail 11.5.2 Teoxane Business Overview 11.5.3 Teoxane Iron Deficiency Anemia Therapy Introduction 11.5.4 Teoxane Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.5.5 Teoxane Recent Development 11.6 Sinclair Pharma 11.6.1 Sinclair Pharma Company Detail 11.6.2 Sinclair Pharma Business Overview 11.6.3 Sinclair Pharma Iron Deficiency Anemia Therapy Introduction 11.6.4 Sinclair Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.6.5 Sinclair Pharma Recent Development 11.7 Pieris 11.7.1 Pieris Company Detail 11.7.2 Pieris Business Overview 11.7.3 Pieris Iron Deficiency Anemia Therapy Introduction 11.7.4 Pieris Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.7.5 Pieris Recent Development 11.8 Pharmacosmos AS 11.8.1 Pharmacosmos AS Company Detail 11.8.2 Pharmacosmos AS Business Overview 11.8.3 Pharmacosmos AS Iron Deficiency Anemia Therapy Introduction 11.8.4 Pharmacosmos AS Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.8.5 Pharmacosmos AS Recent Development 11.9 Johnson & Johnson 11.9.1 Johnson & Johnson Company Detail 11.9.2 Johnson & Johnson Business Overview 11.9.3 Johnson & Johnson Iron Deficiency Anemia Therapy Introduction 11.9.4 Johnson & Johnson Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.9.5 Johnson & Johnson Recent Development 11.10 Luitpold Pharmaceuticals 11.10.1 Luitpold Pharmaceuticals Company Detail 11.10.2 Luitpold Pharmaceuticals Business Overview 11.10.3 Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Introduction 11.10.4 Luitpold Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.10.5 Luitpold Pharmaceuticals Recent Development 11.11 Keryx Biopharmaceuticals 11.11.1 Keryx Biopharmaceuticals Company Detail 11.11.2 Keryx Biopharmaceuticals Business Overview 11.11.3 Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Introduction 11.11.4 Keryx Biopharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.11.5 Keryx Biopharmaceuticals Recent Development 11.12 Vifor Pharma 11.12.1 Vifor Pharma Company Detail 11.12.2 Vifor Pharma Business Overview 11.12.3 Vifor Pharma Iron Deficiency Anemia Therapy Introduction 11.12.4 Vifor Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.12.5 Vifor Pharma Recent Development 11.13 Akebia Therapeutics 11.13.1 Akebia Therapeutics Company Detail 11.13.2 Akebia Therapeutics Business Overview 11.13.3 Akebia Therapeutics Iron Deficiency Anemia Therapy Introduction 11.13.4 Akebia Therapeutics Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) 11.13.5 Akebia Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Iron Deficiency Anemia Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Iron Therapy Table 3. Key Players of Parenteral Iron Therapy Table 4. Key Players of Red Blood Cell Transfusion Table 5. Key Players of Other Table 6. Global Iron Deficiency Anemia Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Iron Deficiency Anemia Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Iron Deficiency Anemia Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Iron Deficiency Anemia Therapy Market Share by Region (2017-2022) Table 10. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Iron Deficiency Anemia Therapy Market Share by Region (2023-2028) Table 12. Iron Deficiency Anemia Therapy Market Trends Table 13. Iron Deficiency Anemia Therapy Market Drivers Table 14. Iron Deficiency Anemia Therapy Market Challenges Table 15. Iron Deficiency Anemia Therapy Market Restraints Table 16. Global Iron Deficiency Anemia Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Iron Deficiency Anemia Therapy Market Share by Players (2017-2022) Table 18. Global Top Iron Deficiency Anemia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iron Deficiency Anemia Therapy as of 2021) Table 19. Ranking of Global Top Iron Deficiency Anemia Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Iron Deficiency Anemia Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Iron Deficiency Anemia Therapy Product Solution and Service Table 23. Date of Enter into Iron Deficiency Anemia Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Iron Deficiency Anemia Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Iron Deficiency Anemia Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Iron Deficiency Anemia Therapy Revenue Market Share by Application (2017-2022) Table 31. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Iron Deficiency Anemia Therapy Revenue Market Share by Application (2023-2028) Table 33. North America Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2023-2028) & (US$ Million) Table 43. Allergan Company Detail Table 44. Allergan Business Overview Table 45. Allergan Iron Deficiency Anemia Therapy Product Table 46. Allergan Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 47. Allergan Recent Development Table 48. AMAG Pharmaceuticals Company Detail Table 49. AMAG Pharmaceuticals Business Overview Table 50. AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Product Table 51. AMAG Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 52. AMAG Pharmaceuticals Recent Development Table 53. Integra Lifesciences Company Detail Table 54. Integra Lifesciences Business Overview Table 55. Integra Lifesciences Iron Deficiency Anemia Therapy Product Table 56. Integra Lifesciences Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 57. Integra Lifesciences Recent Development Table 58. Galderma Pharma Company Detail Table 59. Galderma Pharma Business Overview Table 60. Galderma Pharma Iron Deficiency Anemia Therapy Product Table 61. Galderma Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 62. Galderma Pharma Recent Development Table 63. Teoxane Company Detail Table 64. Teoxane Business Overview Table 65. Teoxane Iron Deficiency Anemia Therapy Product Table 66. Teoxane Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 67. Teoxane Recent Development Table 68. Sinclair Pharma Company Detail Table 69. Sinclair Pharma Business Overview Table 70. Sinclair Pharma Iron Deficiency Anemia Therapy Product Table 71. Sinclair Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 72. Sinclair Pharma Recent Development Table 73. Pieris Company Detail Table 74. Pieris Business Overview Table 75. Pieris Iron Deficiency Anemia Therapy Product Table 76. Pieris Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 77. Pieris Recent Development Table 78. Pharmacosmos AS Company Detail Table 79. Pharmacosmos AS Business Overview Table 80. Pharmacosmos AS Iron Deficiency Anemia Therapy Product Table 81. Pharmacosmos AS Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 82. Pharmacosmos AS Recent Development Table 83. Johnson & Johnson Company Detail Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Iron Deficiency Anemia Therapy Product Table 86. Johnson & Johnson Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 87. Johnson & Johnson Recent Development Table 88. Luitpold Pharmaceuticals Company Detail Table 89. Luitpold Pharmaceuticals Business Overview Table 90. Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Product Table 91. Luitpold Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 92. Luitpold Pharmaceuticals Recent Development Table 93. Keryx Biopharmaceuticals Company Detail Table 94. Keryx Biopharmaceuticals Business Overview Table 95. Keryx Biopharmaceuticals Iron Deficiency Anemia TherapyProduct Table 96. Keryx Biopharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 97. Keryx Biopharmaceuticals Recent Development Table 98. Vifor Pharma Company Detail Table 99. Vifor Pharma Business Overview Table 100. Vifor Pharma Iron Deficiency Anemia TherapyProduct Table 101. Vifor Pharma Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 102. Vifor Pharma Recent Development Table 103. Akebia Therapeutics Company Detail Table 104. Akebia Therapeutics Business Overview Table 105. Akebia Therapeutics Iron Deficiency Anemia TherapyProduct Table 106. Akebia Therapeutics Revenue in Iron Deficiency Anemia Therapy Business (2017-2022) & (US$ Million) Table 107. Akebia Therapeutics Recent Development Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global Iron Deficiency Anemia Therapy Market Share by Type: 2021 VS 2028 Figure 2. Oral Iron Therapy Features Figure 3. Parenteral Iron Therapy Features Figure 4. Red Blood Cell Transfusion Features Figure 5. Other Features Figure 6. Global Iron Deficiency Anemia Therapy Market Share by Application in 2021 & 2028 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Home Healthcare Case Studies Figure 10. Other Case Studies Figure 11. Iron Deficiency Anemia Therapy Report Years Considered Figure 12. Global Iron Deficiency Anemia Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Iron Deficiency Anemia Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Iron Deficiency Anemia Therapy Market Share by Region: 2021 VS 2028 Figure 15. Global Iron Deficiency Anemia Therapy Market Share by Players in 2021 Figure 16. Global Top Iron Deficiency Anemia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iron Deficiency Anemia Therapy as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Iron Deficiency Anemia Therapy Revenue in 2021 Figure 18. North America Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Iron Deficiency Anemia Therapy Market Share by Country (2017-2028) Figure 20. United States Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Iron Deficiency Anemia Therapy Market Share by Country (2017-2028) Figure 24. Germany Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Iron Deficiency Anemia Therapy Market Share by Region (2017-2028) Figure 32. China Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Iron Deficiency Anemia Therapy Market Share by Country (2017-2028) Figure 40. Mexico Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Iron Deficiency Anemia Therapy Market Share by Country (2017-2028) Figure 44. Turkey Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Iron Deficiency Anemia Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Allergan Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 47. AMAG Pharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 48. Integra Lifesciences Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 49. Galderma Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 50. Teoxane Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 51. Sinclair Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 52. Pieris Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 53. Pharmacosmos AS Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 55. Luitpold Pharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 56. Keryx Biopharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 57. Vifor Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 58. Akebia Therapeutics Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2017-2022) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Allergan AMAG Pharmaceuticals Integra Lifesciences Galderma Pharma Teoxane Sinclair Pharma Pieris Pharmacosmos AS Johnson & Johnson Luitpold Pharmaceuticals Keryx Biopharmaceuticals Vifor Pharma Akebia Therapeutics